Novel mTORC1 inhibitors kill Glioblastoma stem cells
J. A. Sandoval, A. Tomilov, S. Datta, S. Allen, R. O'Donnell, J. Angelastro, G. Cortopassi
This paper identifies novel mTORC1 inhibitors that effectively kill GBM stem cells and shows their potential as adjuvant therapy when combined with temozolomide.
bioRxiv · Jun 17, 2020Pharmacology & Toxicology